Evidence map›Paper›PMID 34678377›Full record

ArticleNeuropharmacology2022

Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators.

G France, R Volianskis, R Ingram, N Bannister, R Rothärmel, M W Irvine, G Fang, E S Burnell, K Sapkota, B M Costa and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Altered Structural Plasticity Mediated by mGlu and NMDA Receptors and Impaired Cognition in a Genetic ASD Model (Shank3The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  2. The how and why for multiple forms of hippocampal LTP.Frontiers in synaptic neuroscience · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Frontiers in neuroscience · 2025
    Article
  7. Article
  8. Interplay of hippocampal long-term potentiation and long-term depression in enabling memory representations.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  9. Cage effects on synaptic plasticity and its modulation in a mouse model of fragile X syndrome.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  10. Promiscuous involvement of metabotropic glutamate receptors in the storage ofPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 3 countries.

G FranceSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
R VolianskisDepartment of Physiology, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.
R IngramCentre for Neuroscience, Surgery and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.
N BannisterSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
R RothärmelSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
M W IrvineSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
G FangSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
E S BurnellSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK; University of Exeter, St Luke's Campus, Heavitree Road, Exeter, UK.
K SapkotaDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA.
B M CostaEdward Via College of Osteopathic Medicine, Blacksburg, VA, USA & Center for One Health Research, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
D A ChopraDepartment of Pharmacology and Neuroscience, Creighton University School of Medicine, Omaha, Nebraska, USA.
S M DravidDepartment of Pharmacology and Neuroscience, Creighton University School of Medicine, Omaha, Nebraska, USA.
A T Michael-TitusCentre for Neuroscience, Surgery and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.
D T MonaghanDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA.
J GeorgiouLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.
Z A BortolottoSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
D E JaneSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
G L CollingridgeSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK; Department of Physiology, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada; TANZ Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
A VolianskisSchools of Clinical Sciences and Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK; Centre for Neuroscience, Surgery and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK; School of Biosciences, Museum Avenue, Cardiff University, Cardiff, CF10 3AX, UK. Electronic address: volianskisa@cardiff.ac.uk.
University of Bristol · GBCreighton University · USQueen Mary University of London · GBSinai Health System · CAUniversity of Nebraska Medical Center · USEdward Via College of Osteopathic Medicine · USHeavitree Hospital · GBMount Sinai Hospital · CA

Funding

Development and Pharmacology of Positive Allosteric Modulators of NMDA ReceptorsR01MH060252 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI JANE, DAVID EDWARD, MONAGHAN, DANIEL T · 2001 to 2017
$4.0M
Biotechnology and Biological Sciences Research Council BB/L001977/1CIHR 154276Medical Research Council G0601812Medical Research Council MR/K023098/1NIMH NIH HHS R01 MH060252
6 · The paper itself

Abstract

Different types of memory are thought to rely on different types of synaptic plasticity, many of which depend on the activation of the N-Methyl-D Aspartate (NMDA) subtype of glutamate receptors. Accordingly, there is considerable interest in the possibility of using positive allosteric modulators (PAMs) of NMDA receptors (NMDARs) as cognitive enhancers. Here we firstly review the evidence that NMDA receptor-dependent forms of synaptic plasticity: short-term potentiation (STP), long-term potentiation (LTP) and long-term depression (LTD) can be pharmacologically differentiated by using NMDAR ligands. These observations suggest that PAMs of NMDAR function, depending on their subtype selectivity, might differentially regulate STP, LTP and LTD. To test this hypothesis, we secondly performed experiments in rodent hippocampal slices with UBP714 (a GluN2A/2B preferring PAM), CIQ (a GluN2C/D selective PAM) and UBP709 (a pan-PAM that potentiates all GluN2 subunits). We report here, for the first time, that: (i) UBP714 potentiates sub-maximal LTP and reduces LTD; (ii) CIQ potentiates STP without affecting LTP; (iii) UBP709 enhances LTD and decreases LTP. We conclude that PAMs can differentially regulate distinct forms of NMDAR-dependent synaptic plasticity due to their subtype selectivity.

Indexed as

Allosteric RegulationAnimalsBenzimidazolesHippocampusLong-Term PotentiationLong-Term Synaptic DepressionMaleMiceMice, Inbred C57BLNeuronal PlasticityRatsRats, WistarReceptors, N-Methyl-D-Aspartate2-amino-3-methylimidazo(1,2-d)naphthaleneBenzimidazolesReceptors, N-Methyl-D-AspartateLong-term depressionLong-term potentiationLTDLTPMemoryNMDA receptorsPositive allosteric modulator (PAM)Short-term potentiationSTPSynaptic plasticity

Identifiers

PMID34678377
PMCPMC8803579
OpenAlexW3206417684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.